Kidney grafts from elderly donors;La greffe des reins à partir de donneurs âgés

Presse Medicale

Volumn 32, Issue 20, 2003, Pages 942-951

  Hiesse, Christian ^a   Pessione, Fabienne ^a   Cohen, Sophie ^a  

^a Etablissement Francais des Greffes   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; PENTETATE TECHNETIUM TC 99M; TACROLIMUS;

ACCURACY; AGE; AGING; BIOPSY; CAUSE OF DEATH; DIALYSIS; FRANCE; GLOMERULUS FILTRATION RATE; GRAFT SURVIVAL; HUMAN; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY DONOR; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY GRAFT; KIDNEY ISCHEMIA; KIDNEY PARENCHYMA; KIDNEY TRANSPLANTATION; MEDICAL ASSESSMENT; NEPHRON; PATIENT SELECTION; QUALITY CONTROL; RECIPIENT; REVIEW; RISK FACTOR; SAMPLING; TECHNIQUE; TREATMENT INDICATION; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; CHILD; GRAFT SURVIVAL; HUMANS; KIDNEY TRANSPLANTATION; MIDDLE AGED; TISSUE DONORS; TREATMENT OUTCOME;

EID: 0042092263     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (60)

1. Wolfe RA, Ashby VB, Milford EL et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 1999; 34:1725-30.
2. Basar H, Soran A, Schapiro A et al. Renal transplantation in recipients over the age of 60. Transplantation 1999; 68:1191-3.
3. Tesi RJ, Elkhammas EA, Davies EA, Henry ML, Ferguson RM. Renal transplantation in older people. Lancet 1994; 343:461-4.
4. Landais P. L'insuffisance rénale chronique en France. Epidémiologie de la demande soins. Presse Med 2002; 31:167
5. Rapport annuel de l'Etablissement français des Greffes, 2001.
6. United Network for Organ Sharing. Annual report of the US Scientific Registry for Transplant Recipients and the Organ and Transplant Network. UNOS. Richmond. Va. USA. 1999.
7. Organizacion Nacional des Trasplantes. Revista espanola de trasplantes. 1999; 8:81-9.
8. Nyengaard JR, Bendtsen TF. Glomerular number and size in relation to age, sex, race, and body habitus on kidney weight in humans. Arch Pathol Lab Med 1986; 110:55-9.
9. Kaplan C, Pasternack R, Shah H, Gallo G. Age-related incidence of sclerotic glomeruli in human kidneys. Am J Pathol 1975; 80:227-41.
10. Lindeman RD, Tobin JD, Shock NW. Longitudinal studies on the rate of decline in renal function with age. J Am Geriatr Soc 1985; 33:278-85.
11. Goldberg TH, Finkelstein MS. Difficulties in estimating glomerular filtration rate in the elderly. Arch Int Med 1987; 147:1430-8.
12. Lindeman RD, Tobin JD, Shock NW. Association between blood pressure and the rate of decline of renal function with age. Kidneylnt 1984; 26:861-9.
13. Brenner BM, Milford E. Nephron underdosing: a programmed cause of chronic renal allograft failure. Am J Kidney Dis 1993; 21:66-71.
14. Taal MW, Tilney NL, Brenner BM, Mackenzie HS. Renal mass: An Important determinant of late allograft outcome. Transplant Rev 1998; 12:74-84.
15. Tullius SG, Reutzel A, Egermann F et al. Contribution of prolonged ischemia and donor age to chronic allograft dysfunction. J Am Soc Nephrol 2000; 11:1317-24.
16. Shoskes DA, Cecka JM. Deleterious effects of delayed graft function in cadaveric transplant recipients independent of acute rejection. Transplantation 1998; 66:266-74.
17. McLaren AJ, Jassem W, Gray DW et al. Delayed graft function: risk factors and the relative effects of early function and acute rejection on long-term survival in cadaveric renal transplantation. Clin Transplantation 1999; 13:266-74.
18. Tullius SG, Volk HD, Neuhaus R Transplantation of organs from marginal donors. Transplantation 2001; 72:1341-9.
19. Hetzel GR, Klein B, Brause M et al. Risk factors for delayed graft function after renal transplantation and their significance for long-term clinical outcome. Transplant Int 2002; 15:10-16
20. Cho YW. Expanded criteria donors, in Clinical Transplants 1998, edited by Cecka JM, Terasaki PI, Los Angeles, UCLA Tissue Typing Laboratory, 1998, pp 421-436.
21. Higgins RM, Sheriff R, Bittar AA et al. The quality of function of renal allografts is associated with donor age. Transplant Int 1995; 8:221-5.
22. Cosio FG, Qiu W, Henry ML et al. Factors related to the donor organ are major determinants of renal allograft function and survival. Transplantation 1996; 62:1571-8.
23. Alexander JW, Vaughn WK. The use of "marginal" donors for organ transplantation. The influence of donor age on outcome. Transplantation 1991; 51:135-41.
24. Vivas CA, O'Donovan RM, Jordan ML et al. Cadaveric renal transplantation using kidneys from donors greater than 60 years old. Clin Transplantation 1992; 6:77-82.
25. Feduska NJ and Cecka M. Donor factors, in Clin Transplant 1994, edited by Terasaki PI, Los Angeles, UCLA Tissue Typing Laboratory, 1995, pp 381-393.
26. Terasaki PI, Gjertson DW, Cecka JM, Takemoto S, Cho YW. Significance of the donor age effect on kidney transplants. Clin Transplantation 1997; 11:366-71.
27. Hariharan S, Mc Bride MA, Bennett LE, Cohen EP. Risk factors for renal allograft survival form older cadaver donors. Transplantation 1997; 64:1748-53.
28. Ciciarelli J, Iwaki Y, Mendez R. The influence of donor age on kidney graft survival in the 1990s, in Clin Transplant 1999, edited by Terasaki PI, Los Angeles, UCLA Tissue Typing Laboratory, 2000, pp 335-52.
29. Sola R, Guirado LI, Lopez Navidad A et al. Renal transplantation with limit donors. To what should the good results obtained be attributed? Transplantation 1998; 66:1159-65.
30. Verran DJ, de Leon C, Chui AK, Chapman JR. Factors in older cadaveric organ donors impacting on renal allograft outcome. Clin Transplantation 2001; 15:1-12.
31. Lloveras J, Arias M, Andres A et al. Five-year follow-up of 250 recipients of cadaveric kidney allograft from donors older than 55 years of age. Transplant Proc 1995; 27:981-3.
32. Kuo K, Johnson LB, Schweitzer EJ et al. Utilization of the older donor for renal transplantation. Am J Surg 1996; 172;551-5.
33. Chertow GM, Milford EL, MacKenzie HS, Brenner BM. Antigen-independent determinants of cadaveric kidney transplant failure. JAMA 1996; 276:1732-43.
34. Chertow GM, Brenner BM, Mori M et al. Antigen-independent determinants of graft survival in living-related kidney transplantation. Kidney Int 1997; 63:584-589.
35. Smits JMA, van Houwelingen HC, De Meester JD et al. Permanent detrimental effect of nonimmunological factors on long-term renal graft survival. Transplantation 2000; 70:317-33.
36. Morris PJ, Hohson RJ, Fuggle SV, Belger MA, Briggs JD. Analysis of factors that affect outcome of primary cadaveric renal transplantation in the UK. Lancet 1999; 354:1147-52.
37. Pessione F, Cohen S, Durand D et al. Multivariate analysis of donor risk factors for graft survival in kidney transplantation. Transplantation, 2003; 75:361-7.
38. Ojo AO, Hanson JA, Meier-Kriesche HU et al. Survival in recipients of marginal cadaveric donor kidneys compared with older recipients and wait-listed transplant candidates. J Am Soc Nephrol 2001; 12:589-97.
39. Whiting J Whiting JF, Golconda M et al. Economic cost of expanded criteria donors in renal transplantation. Transplantation 1998; 65:204-07.
40. Whiting JF, Woodward RS, Zavala EY et al. Economic cost of expanded criteria donors in cadaveric renal transplantation: analysis of Medicare payments. Transplantation 2000; 70:755-60.
41. Di Paolo S, Stallone G, Schena et al. Hypertension is an independent predictor of delayed graft function and worse renal function only in kidneys with chronic pathological lesions. Transplantation 2002; 73:623-27.
42. Ojo AO, Leichtman AB, Punch JD et al. Impact of pre-existing donor hypertension and diabetes mellitus on cadaveric renal transplant outcomes. Am J Kidney Dis 2000; 36:353-9.
43. Carter JT, Lee CM, Weinstein RJ, Lu AD, Dafoe DC, Alfrey EJ. Evaluation of the older cadaveric donor hypertension and creatinine clearance on graft performance and survival. Transplantation 2000; 70:765-74.
44. Lenglet JE, Lijkwan MA, De Meester J et al. Long-term survival of donor kidneys is predicted by serum creatinine at the time of brain death. Organ and Tissues 2001; 2:79-85.
45. Lee CM, Scandling JD, Pavlakis M et al. A review of the kidneys that nobody wanted. Determinants of optimal outcome. Transplantation 1998; 65:213-19.
46. Randhawa P. Role of donor kidney biopsies in renal transplantation. Transplantation 2001; 71:1361-5.
47. Gaber LW, Moore LW, Amiri MH, Vera SR, Gaber AO. Glomerulosclerosis as a determinant of posttransplant function of older donor renal allografts. Transplantation 1995; 60:354-7.
48. Lehtonen SR, Taskinen El, Isoniemi HM. Histopathological findings in renal allograft at time of transplantation and correlation with onset of graft function. APMIS 1999; 107:945-59.
49. Pokorna E, Vitko S, Chadimova M, Schück O, Ekberg H. Proportion of glomerulosclerosis in procurement wedge renal biopsy cannot discriminate for acceptance of marginal donors. Transplantation 2000; 69:36-43.
50. Muruwe NA, Steinbecker KM, Luger AM. Are wedge biopsies of cadaveric kidneys obtained at procurement reliable ? Transplantation 2000; 69:2384-88.
51. Waiser J, Schreiber M, Budde K et al. Age-matching in renal transplantation. Nephrol Dial Transplant 2000; 15:696-700.
52. Cecka JM, Terasaki PI. Matching kidneys for size in renal transplantation. Clin Transplantation 1990; 4:82-6.
53. Schlieper G, Ivens K, Voiculescu A et al. Eurotransplant Senior Program "old for old": results from 10 patients. Clin Transplantation 2001; 15:100-5.
54. Lee CM, Scandling JD, Shen GK, Salvatierra O, Dafoe DC, Alfrey EJ. The kidneys that nobody wanted. Transplantation 1996; 62:1832-41.
55. Lu AD, Carter JT, Weinstein RJ, Stratta et al. Outcome in recipients of dual kidney transplants. An analysis of the dual registry patients. Transplantation 2000; 69:281-5.
56. Grinyo JM, Gil-Vernet S, Seron D et al. Primary immunosuppression with mycophenolate mofetil and antithymocyte globulin for kidney transplant recipients of a suboptimal graft. Nephrol Dial Transplant 1998; 13:2601-4.
57. Hueso M, Bover J, Seron D et al. Low dose cyclosporine and mycophenolate mofetil in renal allograft recipients with suboptimal renal function. Transplantation 1998; 66:1727-31.
58. Hricik DE. Target of rapamycin (TOR) inhibition in renal transplantation: Clinical use in various populations. Am J KidneyDis 2001; 38:51-2.
59. Tran HT, Acharya MK, McKay DB et al. Avoidance of cyclosporine in renal transplantation: effects of daclizumab, mycophenolate mofetil, and steroids. J Am Soc Nephrol 2000; 11:1933-6.
60. Slakey DP, Patel S, Joseph V, Edwin D, Burdick J, Ratner LE. Patient acceptance of cadaveric kidneys from expanded criteria donors. Transplant Proc 1997; 29:116-17.